Lv3
352 积分 2025-07-31 加入
CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format
16天前
已完结
BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus
16天前
已完结
GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
25天前
已关闭
Cellular and proteomic changes following administration of peresolimab in patients with rheumatoid arthritis: a post-hoc analysis of a randomised phase 2a trial
25天前
已完结
Solute carrier family 15 member 4, an emerging therapeutic target for systemic lupus erythematosus
1个月前
已完结
TLR7 in systemic lupus erythematosus: genetics and emerging therapies
1个月前
已完结
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
2个月前
已完结
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
2个月前
已完结
OP0221 LBL-047, A NOVEL AFUCOSYLATED ANTI-BDCA2/TACI FUSION PROTEIN WITH YTE MUTATION, INHIBITS THE FUNCTIONS OF BOTH pDCs AND B CELLS
2个月前
已完结